Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
Clinical trial NCT04920149 · RECRUITING
Trial details
- NCT number
- NCT04920149
- Sponsor
- Ann-Sofie Backman
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2032-09-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.